학술논문

Deep learning-based phenotyping reclassifies combined hepatocellular-cholangiocarcinoma
Document Type
article
Author
Julien CalderaroNarmin Ghaffari LalehQinghe ZengPascale MailleLoetitia FavreAnaïs PujalsChristophe KleinCéline BazilleLara R. HeijArnaud UguenTom LueddeLuca Di TommasoAurélie BeaufrèreAugustin ChatainDelphine GastineauCong Trung NguyenHiep Nguyen-CanhKhuyen Nguyen ThiViviane GnemmiRondell P. GrahamFrédéric CharlotteDominique WendumMukul VijDaniela S. AllendeFederico AucejoAlba DiazBenjamin RivièreAstrid HerreroKatja EvertDiego Francesco CalvisiJérémy AugustinWei Qiang LeowHoward Ho Wai LeungEmmanuel BoleslawskiMohamed RelaArnaud FrançoisAnthony Wing-Hung ChaAlejandro FornerMaria ReigManon AllaireOlivier ScattonDenis ChatelainCamille Boulagnon-RombiNathalie SturmBenjamin MenahemEric FrouinDavid TougeronChristophe TournigandEmmanuelle KempfHaeryoung KimMassih NingarhariSophie Michalak-ProvostPurva GopalRaffaele BrustiaEric VibertKornelius SchulzeDarius F. RütherSören A. WeidemannRami RhaiemJean-Michel PawlotskyXuchen ZhangAlain LucianiSébastien MuléAlexis LaurentGiuliana AmaddeoHélène RegnaultEleonora De MartinChristine SempouxPooja NavaleMaria WesterhoffRegina Cheuk-Lam LoJan BednarschAnnette GouwCatherine GuettierMarie LequoyKenichi HaradaPimsiri SripongpunPoowadon WetwittayaklangNicolas LoménieJarukit TantipisitApichat KaewdechJeanne ShenValérie ParadisStefano CarusoJakob Nikolas Kather
Source
Nature Communications, Vol 14, Iss 1, Pp 1-10 (2023)
Subject
Science
Language
English
ISSN
2041-1723
Abstract
Abstract Primary liver cancer arises either from hepatocytic or biliary lineage cells, giving rise to hepatocellular carcinoma (HCC) or intrahepatic cholangiocarcinoma (ICCA). Combined hepatocellular- cholangiocarcinomas (cHCC-CCA) exhibit equivocal or mixed features of both, causing diagnostic uncertainty and difficulty in determining proper management. Here, we perform a comprehensive deep learning-based phenotyping of multiple cohorts of patients. We show that deep learning can reproduce the diagnosis of HCC vs. CCA with a high performance. We analyze a series of 405 cHCC-CCA patients and demonstrate that the model can reclassify the tumors as HCC or ICCA, and that the predictions are consistent with clinical outcomes, genetic alterations and in situ spatial gene expression profiling. This type of approach could improve treatment decisions and ultimately clinical outcome for patients with rare and biphenotypic cancers such as cHCC-CCA.